Robeco Institutional Asset Management B.V. Sells 304,270 Shares of The Clorox Company $CLX

Robeco Institutional Asset Management B.V. cut its holdings in The Clorox Company (NYSE:CLX) by 48.4% during the fourth quarter, Holdings Channel reports. The institutional investor owned 324,751 shares of the company’s stock after selling 304,270 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Clorox were worth $32,745,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of CLX. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Clorox by 4.0% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock worth $1,970,000 after buying an additional 514 shares during the period. Woodline Partners LP grew its position in shares of Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after buying an additional 7,465 shares during the period. Baird Financial Group Inc. grew its position in shares of Clorox by 1.7% in the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after buying an additional 424 shares during the period. Jump Financial LLC grew its position in shares of Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after buying an additional 7,924 shares during the period. Finally, Bank of Nova Scotia grew its position in shares of Clorox by 26.2% in the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock worth $1,938,000 after buying an additional 3,352 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Performance

Shares of CLX stock opened at $103.44 on Tuesday. The Clorox Company has a one year low of $96.66 and a one year high of $143.96. The company’s 50-day moving average is $113.96 and its 200 day moving average is $110.66. The company has a market capitalization of $12.51 billion, a price-to-earnings ratio of 16.90, a price-to-earnings-growth ratio of 0.52 and a beta of 0.65. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the company posted $1.55 earnings per share. The business’s revenue for the quarter was down .8% compared to the same quarter last year. Sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Wednesday, April 22nd will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date of this dividend is Wednesday, April 22nd. Clorox’s dividend payout ratio (DPR) is presently 81.05%.

Analyst Ratings Changes

A number of research firms have recently weighed in on CLX. UBS Group reduced their target price on shares of Clorox from $121.00 to $110.00 and set a “neutral” rating on the stock in a research report on Tuesday, April 7th. Royal Bank Of Canada reduced their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $114.00 to $117.00 and gave the company a “neutral” rating in a research report on Wednesday, February 4th. Wells Fargo & Company cut their price objective on shares of Clorox from $125.00 to $110.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 8th. Finally, The Goldman Sachs Group cut their price objective on shares of Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research report on Wednesday, January 7th. One analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Reduce” and a consensus price target of $115.93.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.